Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Temas Resources Corp (OP: TMASF )

0.1850 +0.0150 (+8.82%)
Streaming Delayed Price Updated: 3:37 PM EDT, May 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 172,244
Open 0.1777
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.1700
Today's Range 0.1740 - 0.1850
52wk Range 0.0055 - 0.3200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Temas Resources Completes First Tranche of Private Placement
Via ACCESSWIRE
Temas Files Preliminary Economic Assessment Report for La Blache and Clarifies February 7th Release
Via ACCESSWIRE

Performance

YTD
-1.49%
-1.49%
1 Month
+28.92%
+28.92%
3 Month
-12.07%
-12.07%
6 Month
+83.71%
+83.71%
1 Year
+1441.67%
+1441.67%

More News

Read More
Temas Announces Option Agreement To Acquire the La Blache Lake Extension Property
Via ACCESSWIRE
Temas Resources to Present at the 2024 Kinvestor Critical Minerals & Mining Virtual Conference
Via ACCESSWIRE
Temas Resources announces termination of Piskanja Boron Project Option Agreement and Management Changes
From Temas Resources Corp.
Via Business Wire
Final Approvals Received  - Temas to Proceed with Strategic Partnership on the Piskanja Boron Project
From Temas Resources Corp.
Via Business Wire
Temas Resources and Erin Ventures Ready Agreement for the Joint Development of Piskanja Boron Project
From Temas Resources Corp.
Via Business Wire
Temas Resources Acquires 50% of Green Mineral Process Developer ORF Technologies Inc.
From Temas Resources Corp.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.